A Prospective, Multicenter, Double-Blind, Randomized Trial of Bladder Instillation of Liposome Formulation OnabotulinumtoxinA for Interstitial Cystitis/Bladder Pain Syndrome
Author:
Affiliation:
1. Department of Urology, Kaohsiung Chang Gang Memorial Hospital, College of Medicine, Chang Gung University, Hualien, Taiwan
2. Department of Urology, Buddhist Tzu Chi General Hospital and Tzu Chi University, Hualien (HCK), Taiwan
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Urology
Reference25 articles.
1. Status of international consensus on interstitial cystitis/bladder pain syndrome/painful bladder syndrome: 2008 snapshot;Hanno;Neurourol Urodyn,2009
2. Prevalence of symptoms of bladder pain syndrome/interstitial cystitis among adult females in the United States;Berry;J Urol,2011
3. Investigational drugs for bladder pain syndrome (BPS)/interstitial cystitis (IC);Chuang;Expert Opin Invest Drugs,2016
4. Interstitial cystitis: an unsolved enigma;Moutzouris;Clin J Am Soc Nephrol,2009
5. Diagnosis and treatment of interstitial cystitis/bladder pain syndrome: AUA guideline amendment;Hanno;J Urol,2015
Cited by 57 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Efficacy, Satisfaction, and Compliance: Insights from 15 Years of Botulinum Toxin Use for Female Urgency Urinary Incontinence;Toxins;2024-07-26
2. Promising Experimental Treatment in Animal Models and Human Studies of Interstitial Cystitis/Bladder Pain Syndrome;International Journal of Molecular Sciences;2024-07-23
3. Embracing the Versatility of Botulinum Neurotoxins in Conventional and New Therapeutic Applications;Toxins;2024-06-04
4. A randomized-controlled pilot trial of telemedicine-delivered cognitive-behavioral therapy tailored for interstitial cystitis/bladder pain syndrome;Pain;2024-02-27
5. Use and Outcomes of Botulinum Toxin A for Both Neurogenic and Non-neurogenic Voiding Dysfunction in the Pediatric Patient;Current Bladder Dysfunction Reports;2024-02-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3